Showing 11,001 - 11,020 results of 224,509 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((latent decrease) OR (larger decrease)) ))', query time: 1.48s Refine Results
  1. 11001

    Data_Sheet_5_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF by Shin-ichiro Hattori (5767388)

    Published 2018
    “…Here, we focused on a second mitochondria-derived activator of caspases (Smac) mimetic, birinapant, to induce apoptosis in latent HIV-1-infected cells. …”
  2. 11002

    Data_Sheet_2_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF by Shin-ichiro Hattori (5767388)

    Published 2018
    “…Here, we focused on a second mitochondria-derived activator of caspases (Smac) mimetic, birinapant, to induce apoptosis in latent HIV-1-infected cells. …”
  3. 11003

    Data_Sheet_3_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF by Shin-ichiro Hattori (5767388)

    Published 2018
    “…Here, we focused on a second mitochondria-derived activator of caspases (Smac) mimetic, birinapant, to induce apoptosis in latent HIV-1-infected cells. …”
  4. 11004
  5. 11005
  6. 11006
  7. 11007
  8. 11008
  9. 11009
  10. 11010
  11. 11011
  12. 11012

    Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists by Dilip K. Tosh (1668115)

    Published 2018
    “…While screening off-target effects of rigid (<i>N</i>)-methanocarba-adenosine 5′-methylamides as A<sub>3</sub> adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). …”
  13. 11013

    Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists by Dilip K. Tosh (1668115)

    Published 2018
    “…While screening off-target effects of rigid (<i>N</i>)-methanocarba-adenosine 5′-methylamides as A<sub>3</sub> adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). …”
  14. 11014
  15. 11015

    Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists by Dilip K. Tosh (1668115)

    Published 2018
    “…While screening off-target effects of rigid (<i>N</i>)-methanocarba-adenosine 5′-methylamides as A<sub>3</sub> adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). …”
  16. 11016

    Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists by Dilip K. Tosh (1668115)

    Published 2018
    “…While screening off-target effects of rigid (<i>N</i>)-methanocarba-adenosine 5′-methylamides as A<sub>3</sub> adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). …”
  17. 11017
  18. 11018
  19. 11019

    Results of Experiment S1 as a function of Stimulus Type. by İlayda Nazlı (19332772)

    Published 2024
    “…<p>(a-b) Across participants’ mean reaction times as a function of Expectation (expected / unexpected) and Condition (antedating / blocked / control) in leading objects (a) and leading shapes (b). …”
  20. 11020

    A single-reaction knock-out study for the AABSM. by William C. Carlquist (2412412)

    Published 2023
    “…Greater values of and AIC − AIC<sub>∅</sub> correspond to a larger decrease in the quality of the fit. The reactions are grouped with related reactions and ordered by their AIC difference from the complete AABSM for the oscillation data. …”